Terry Day to Survival Rate
This is a "connection" page, showing publications Terry Day has written about Survival Rate.
Connection Strength
1.123
-
Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2019 02 01; 145(2):166-177.
Score: 0.133
-
Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer. Otolaryngol Head Neck Surg. 2018 04; 158(4):649-659.
Score: 0.123
-
Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base. Cancer. 2017 Jun 15; 123(12):2248-2257.
Score: 0.116
-
Prognostic Factors in Myoepithelial Carcinoma of the Major Salivary Glands. Otolaryngol Head Neck Surg. 2016 06; 154(6):1047-53.
Score: 0.109
-
Predictors of Nodal Metastasis in Parotid Malignancies: A National Cancer Data Base Study of 22,653 Patients. Otolaryngol Head Neck Surg. 2016 Jan; 154(1):121-30.
Score: 0.105
-
A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014 Apr; 140(4):331-7.
Score: 0.095
-
Well differentiated thyroid carcinoma: current treatment. Curr Treat Options Oncol. 2012 Mar; 13(1):47-57.
Score: 0.082
-
Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users. Arch Otolaryngol Head Neck Surg. 2007 Jan; 133(1):28-31.
Score: 0.058
-
The use of temporal polyethylene implant after temporalis myofascial flap transposition: clinical and radiographic results from its use in 21 patients. J Oral Maxillofac Surg. 2006 Jan; 64(1):12-22.
Score: 0.054
-
Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation. Otolaryngol Head Neck Surg. 2021 10; 165(4):536-549.
Score: 0.038
-
Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1109-1119.
Score: 0.038
-
Prognostic Impact of High-Risk Pathologic Features in HPV-Related Oropharyngeal Squamous Cell Carcinoma and Tobacco Use. Otolaryngol Head Neck Surg. 2019 05; 160(5):855-861.
Score: 0.033
-
Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1068-74.
Score: 0.026
-
Perioperative survival of elderly head and neck squamous cell carcinoma patients. Laryngoscope. 2014 Oct; 124(10):2281-6.
Score: 0.024
-
Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer. Laryngoscope. 2010 Feb; 120(2):236-42.
Score: 0.018
-
Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers. Head Neck. 2009 Apr; 31(4):493-502.
Score: 0.017
-
Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope. 2008 Jul; 118(7):1180-5.
Score: 0.016
-
Proximal esophageal stenosis in head and neck cancer patients after total laryngectomy and radiation. ORL J Otorhinolaryngol Relat Spec. 2008; 70(4):229-35.
Score: 0.016
-
Cranial neuropathy as a presenting sign of recurrent aggressive skin cancer. Dermatol Surg. 2008 Apr; 34(4):483-97.
Score: 0.016
-
Use of P-32 in stage III epithelial carcinoma of the ovary. Gynecol Oncol. 1994 Jul; 54(1):35-9.
Score: 0.006